CTSI is accepting Letters of Intent through noon, April 30 for its junior faculty scholar program that aims to develop the next generation of clinical and translational investigators through structured training with a mentored, multidisciplinary clinical research emphasis.
A new RFA is available through the Translational Product Development Fund for projects that have the potential to be commercialized through the formation of a start-up company or execution of a license agreement with an established commercial entity; apply by Feb. 7.
CTSI will provide up to 10 undergraduate students and up to 10 doctoral-level students opportunities in its summer 2018 research career development programs; apply by Feb. 5.
Community members and organizations interested in developing ideas and partnerships to address health in Minnesota communities now have access to two funding programs through CTSI's Community Engagement to Advance Research and Community Health that will award up to $7,000 each quarter.
CTSI and the Pediatric Device Innovation Consortium award four University of Minnesota research projects with funding and project support to develop pediatric medical devices.
Four research teams have been awarded up to $50,000 each to pursue health research projects that have the potential to lead to a start-up company or license agreement. If successful, the University of Minnesota and Mayo Clinic grantees will be eligible to apply for up to $400,000 in additional funding.
One way CTSI and The Pediatric Device Innovation Consortium (PDIC) have teamed up to advance rare disease research is by supporting the efforts of Dr. Kyriakie Sarafoglou, as she explores better ways to help children with adrenal insufficiency.
Kids with this rare condition lack intrinsic steroid production, so simple childhood illnesses can cause them to get very sick and even become life-threatening.
There’s a new funding opportunity for University of Minnesota researchers developing diagnostics and treatments for rare diseases, thanks to the recent release of an RFA from CTSI’s Translational Grant Program. CTSI anticipates funding up to two projects, with each project receiving as much as $50,000 in direct costs for one year.
CTSI has released a new RFA for the Translational Product Development Fund, which supports projects that have the potential to be commercialized, such as projects that may lead to the formation of a start-up company or execution of a license agreement with an established commercial entity.
CTSI will provide up to 10 undergraduate students and up to five doctoral-level students opportunities in its summer 2017 research career development programs; apply by January 19, 2017.
- Academic Health Center / Health Sciences (37)
- Accelerating discoveries (55)
- Advancing child health discoveries (27)
- Biomedical informatics (22)
- Biostatistical support (15)
- BLS (BioNet) (7)
- BMIP (25)
- BPIC (12)
- CEARCH (66)
- Clinical data repository (12)
- Clinical research professional (10)
- Clinical research services (45)
- Clinical trial management system / OnCore (10)
- Clinical trials (26)
- Community engagement in research (74)
- Community Engagement Studio (2)
- Community Research Institute (1)
- CTR Portal (5)
- CTRS (34)
- CTSA consortium (17)
- CTSI event (32)
- CTSI-Ed (90)
- Early-stage research (39)
- Fairview Research Administration (11)
- Grant (81)
- i2b2 (5)
- Interdisciplinary research (10)
- M Health (6)
- MARCH (1)
- Multisite research (14)
- NCATS (23)
- NIH (26)
- ODAT (47)
- Participate in a study (9)
- PCORI (3)
- Pilot funding (38)
- REDCap (6)
- Regulatory support (10)
- Research career & workforce development (91)
- Research mentor (43)
- Research participant recruitment (15)
- Research Toolkit (3)
- Research tools (38)
- ResearchMatch (2)
- RFA (30)
- Specimen procurement (6)
- StudyFinder (10)
- Team Science (39)
- University of Minnesota (163)